Using EEG to guide anesthesia for seizures after cardiac arrest
Official title: buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest (RESTORE)
Run by University of California, San Francisco · NCT05851391 · Data updated 2026-11-12
This study is testing two different ways of using EEG to guide anesthesia in patients who have had a cardiac arrest and are experiencing severe seizures, to see which method works better at controlling those seizures.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | August 7, 2023 |
| Main results expected | November 30, 2027 |
| Study ends | April 30, 2028 |
| Registry record updated | July 29, 2026 |
| Trial ID | NCT05851391 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have experienced a non-traumatic out-of-hospital cardiac arrest and are comatose upon admission.
✕Probably not a fit
Patients with acute cerebral hemorrhage or infarction, pregnant individuals, and prisoners will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the safety and feasibility of two different EEG-guided anesthesia approaches for treating refractory status epilepticus in patients who have survived cardiac arrest. Participants will be randomly assigned to receive either burst suppression or seizure suppression anesthesia for 24 hours, with the possibility of repeating the intervention if seizures recur. The study aims to determine which EEG target is more effective in controlling seizures following cardiac arrest. The trial will involve continuous EEG monitoring to confirm the diagnosis of post-cardiac arrest refractory status epilepticus.
Why it matters
Potential benefit: If successful, this approach could improve seizure control and outcomes for patients recovering from cardiac arrest.
How similar studies have gone: While the use of EEG-guided anesthesia is established, this specific comparison of burst suppression versus seizure suppression in post-cardiac arrest patients is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years old 2. Non-traumatic, out-of-hospital cardiac arrest 3. Comatose on admission - defined as not following commands 4. Return of spontaneous circulation (ROSC) within less than 45 minutes 5. Admission to the intensive care unit 6. Diagnosis of post-cardiac arrest refractory status epilepticus confirmed with continuous EEG monitoring within 7 days from ROSC Exclusion Criteria: 1. Acute cerebral hemorrhage or infarction 2. Pregnancy 3. Prisoners
Where it's running
-
Zuckerberg San Francisco General Hospital
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Edilberto Amorim, MD — Assistant Professor of Neurology
- Study coordinator: Edilberto Amorim, MD
- Email: restorestudy@ucsf.edu
- Phone: 628-206-3203
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using perampanel to prevent seizures after cardiac arrest
This study is testing if the medication perampanel can help prevent seizures in patients who have survived a cardiac arrest and are in a coma.
-
Creation of a database linking EEG recordings with clinical information for epilepsy patients
This study is creating a database that links brain wave recordings and medical information from epilepsy patients to see if it can help improve treatment and predict seizures better.
-
Recovery after coma from serious brain injury or illness
This observational study will follow adults who are unconscious due to a serious brain illness or injury to see what medical, neurological, psychological, and social factors are linked with recovery over time.
-
Augmented kidney clearance in neurocritical care
This project will test whether adults in the neuro-ICU with severe brain injury, stroke, seizures, or brain infections have faster kidney clearance (ARC) that can lower antiseizure and antibiotic drug levels.
-
Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease
This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.
-
Recognizing seizures in the intensive care unit
This project tests how well NHS neurophysiology scientists, neurologists, intensivists, and ICU nurses can identify seizures from digital video recordings of ICU events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.